Search Within

Margaret Kathleen Callahan

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (24)
  3. Editorial (1)
Groups
  1. Department of Medicine (57)
  2. Epidemiology and Biostatistics (57)
  3. Melanoma and Immunotherapeutics Service (57)
  4. Solid Tumor Oncology Division (57)
  5. Biostatistics Service (50)
  6. GSK Faculty (45)

More Groups

People
  1. Jedd Wolchok (40)
  2. Katherine Panageas (38)
  3. Michael Postow (37)
  4. Paul Chapman (31)
  5. Alexander Shoushtari (28)
  6. Parisa Momtaz (22)

More People

Years
  1. 2024 (2)
  2. 2023 (5)
  3. 2022 (5)
  4. 2021 (6)
  5. 2020 (10)
  6. 2019 (6)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Journal for ImmunoTherapy of Cancer (4)
  3. Annals of Surgical Oncology (3)
  4. Clinical Cancer Research (3)
  5. JCO Precision Oncology (3)
  6. The Oncologist (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. American Association for Cancer Research (4)
  3. Biomed Central Ltd (4)
  4. Oxford University Press (4)
  5. Wiley Blackwell (4)
  6. Springer (3)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO)
    Meeting Abstract

    Gupta, A.; Whiting, K.; Keegan, N. M.; Schmalz, J.; Al-Ahmadie, H. A.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Iyer, G.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma
    Journal Article

    Vanguri, R. S.; Smithy, J. W.; Li, Y.; Zhuang, M.; Maher, C. A.; Aleynick, N.; Peng, X.; Al-Ahmadie, H.; Funt, S. A.; Rosenberg, J. E.; more...
    Journal of Pathology (2023)

    Fulltext@MSK | Save
  • A topic modeling approach reveals the dynamic T cell composition of peripheral blood during cancer immunotherapy
    Journal Article

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Postow, M. A.; Callahan, M. K.; Panageas, K. S.; Shen, R.
    Cell Reports Methods (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Uncovering the hidden structure of T cell compositions in peripheral blood after immune checkpoint inhibitor
    Meeting Abstract

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Callahan, M.; Panageas, K.; Shen, R.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Adaptive dosing of nivolumab + ipilimumab immunotherapy based upon early, interim radiographic assessment in advanced melanoma (The ADAPT-IT study)
    Journal Article

    Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; Smithy, J. W.; Naito, E.; Cugliari, M. K.; Raber, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save